Zobrazeno 1 - 10
of 16 159
pro vyhledávání: '"Primary Immunodeficiency"'
Autor:
Maimaris J; University College London UCL Institute of Immunity and Transplantation, London, UK. j.maimaris@ucl.ac.uk.; Paediatric Immunology Department, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, UK. j.maimaris@ucl.ac.uk., Roa-Bautista A; Immunology department, Manchester University Hospital National Health Service (NHS) Foundation Trust, Manchester, UK., Sohail M; Paediatric department, Barts Hospital National Health Service (NHS) Foundation Trust, London, UK., Booth C; Paediatric Immunology Department, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK., Cugno C; Advanced Cell Therapy Core, Research Department, Sidra Medicine, Doha, Qatar.; Pediatric Oncology, Haematology and Bone Marrow Transplantation Unit, Sidra Medicine, Doha, Qatar., Chenchara L; Pediatric Oncology, Haematology and Bone Marrow Transplantation Unit, Sidra Medicine, Doha, Qatar., Omran TB; Genetics and Genomic Medicine Department, Sidra Medicine, Doha, Qatar., Hacohen Y; Department of Paediatric Neurology, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, UK., Lim M; Children's Neurosciences, Evelina London Children's Hospital Neurosciences Department, London, UK.; Faculty of Life Sciences and Medicine, King's College London, London, UK., Gilmour K; Paediatric Immunology Department, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK., Griffiths G; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Rao K; UCL Great Ormond Street Institute of Child Health, London, UK.; Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Children NHS Trust, London, UK., Elfeky R; Paediatric Immunology Department, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK., Kusters M; Paediatric Immunology Department, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Nov 28; Vol. 45 (1), pp. 50. Date of Electronic Publication: 2024 Nov 28.
Autor:
Roland L; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Nguyen CH; X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria., Zmajkovicova K; X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria., Khamyath M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Kalogeraki M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Schell B; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Gourhand V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Rondeau V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Abou Nader Z; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Monticelli H; X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria., Maierhofer B; X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria., Johnson R; X4 Pharmaceuticals Inc, Boston, MA, United States., Taveras A; X4 Pharmaceuticals Inc, Boston, MA, United States., Espéli M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Balabanian K; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Nov 11; Vol. 15, pp. 1468823. Date of Electronic Publication: 2024 Nov 11 (Print Publication: 2024).
Autor:
Huang Y; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.; Department of Hematology Oncology, Children's Hospital of Chongqing Medical University, Chongqing, China., Li L; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China., Chen R; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China., Yu L; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China., Zhao S; Department of Biology, School of Arts and Sciences, Tufts University, Medford, MA, United States., Jia Y; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China., Dou Y; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.; Department of Hematology Oncology, Children's Hospital of Chongqing Medical University, Chongqing, China., Zhang Z; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Department of Rheumatism and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, China., An Y; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Department of Rheumatism and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, China., Tang X; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Department of Rheumatism and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, China., Zhao X; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.; Department of Rheumatism and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, China., Zhou L; National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Nov 07; Vol. 15, pp. 1460990. Date of Electronic Publication: 2024 Nov 07 (Print Publication: 2024).
Autor:
Rondeau V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Kalogeraki M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Roland L; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Nader ZA; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Gourhand V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Bonaud A; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Lemos J; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Khamyath M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Moulin C; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Schell B; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Delord M; Direction à la Recherche Clinique et à l'Innovation, Centre Hospitalier de Versailles, Le Chesnay, France., Bidaut G; Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Lecourt S; INSERM U1279, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France., Freitas C; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Anginot A; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Mazure N; Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Nice, France., McDermott DH; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Parietti V; Université Paris Cité, UMS Saint-Louis INSERM U53/UAR2030, Paris, France., Setterblad N; Université Paris Cité, UMS Saint-Louis INSERM U53/UAR2030, Paris, France., Dulphy N; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Bachelerie F; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, Orsay, France., Aurrand-Lions M; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.; Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Stockholm D; PSL Research University, EPHE, Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France., Lobry C; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U944, Paris, France., Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Espéli M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Mancini SJC; Univ Rennes, INSERM, EFS, UMR S1236, Rennes, France., Balabanian K; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.
Publikováno v:
Science signaling [Sci Signal] 2024 Oct 29; Vol. 17 (860), pp. eadl5100. Date of Electronic Publication: 2024 Oct 29.
Autor:
Garcia-Carmona Y; Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Chavez J; Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Gernez Y; Department of Medicine, Stanford School of Medicine, Stanford, CA., Geyer JT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Bussel JB; Departments of Pediatrics, Medicine and Obstetrics, Weill Cornell School of Medicine, New York, NY., Cunningham-Rundles C; Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 08; Vol. 8 (19), pp. 5126-5136.
Molecular mechanisms for DNA methylation defects induced by ICF syndrome-linked mutations in DNMT3B.
Autor:
Cho CC; Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, ROC., Fei CY; Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, ROC., Jiang BC; Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, ROC., Yang WZ; Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, ROC., Yuan HS; Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, ROC.; Graduate Institute of Biochemistry and Molecular Biology, National Taiwan University, Taipei, Taiwan, ROC.
Publikováno v:
Protein science : a publication of the Protein Society [Protein Sci] 2024 Oct; Vol. 33 (10), pp. e5131.
Autor:
Zmajkovicova K; X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria., Nykamp K; Invitae, San Francisco, CA, United States., Blair G; Division of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL, United States.; Division of Allergy & Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Yilmaz M; Division of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL, United States.; Division of Allergy & Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Walter JE; Division of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL, United States.; Division of Allergy & Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.; Division of Allergy and Immunology, Massachusetts General Hospital for Children, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 08; Vol. 15, pp. 1411141. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).
Autor:
Wang W; McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.; Department of Microbiology, Genetics and Immunology, Michigan State University, East Lansing, Michigan, United States of America., Pope A; McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America., Ward-Shaw E; McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America., Buehler D; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America., Bachelerie F; Inflammation, Microbiome and Immunosurveillance, INSERM UMR-996, Université Paris-Saclay, Orsay, France., Lambert PF; McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2024 Sep 03; Vol. 20 (9), pp. e1012472. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024).
Autor:
Hardikar S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ren R; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ying Z; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhou J; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Horton JR; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bramble MD; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Liu B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA., Lu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Liu B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Coletta LD; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shen J; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dan J; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang X; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cheng X; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA., Chen T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Publikováno v:
Science advances [Sci Adv] 2024 Aug 23; Vol. 10 (34), pp. eadr0036. Date of Electronic Publication: 2024 Aug 23.
Autor:
Burns SO; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom.; Royal Free London National Health System (NHS) Foundation Trust, London, United Kingdom., Mahlaoui N; Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; French National Reference Center for Primary Immunodeficiencies (CEREDIH), Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Transition Care platform for Adolescents and Young Adults with Rare or Chronic Diseases « La Suite », Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Aug 19; Vol. 15, pp. 1467284. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).